Work

10.4172/2157-2518.1000169

Year: 2014

Type: article

Abstract: Vemurafenib is a selective inhibitor of mutated B-Raf protein, which is found in 60% of metastatic melanoma.Neoadjuvant Vemurafenib for patient with metastatic melanoma, to decrease tumor size prior to surgical resection has been reported in patients with metastatic melanoma to the brain and lymph nodes.We present a case of neoadjuvant Vemurafenib in a patient with large borderline resectable metastatic melanoma to the liver.

Source: Journal of Carcinogenesis & Mutagenesis

DOI: 10.4172/2157-2518.1000169

Author: Yifei Sun

Institution: Saint Louis University

Language: German

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2547699664

FWCI: 0.244

Cites: 12

Cited by: 2

Related to: 10